Decibel Therapeutics Price on December 1, 2024
DBTXDelisted Stock | USD 3.08 0.02 0.65% |
If you're considering investing in Decibel Stock, it is important to understand the factors that can impact its price. As of today, the current price of Decibel Therapeutics stands at 3.08, as last reported on the 3rd of December, with the highest price reaching 3.26 and the lowest price hitting 2.97 during the day. We have found eight technical indicators for Decibel Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Decibel Therapeutics' Rate Of Daily Change of 0.99, day typical price of 3.1, and Day Median Price of 3.12 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
Decibel Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Decibel |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
DBTX |
Based on monthly moving average Decibel Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Decibel Therapeutics by adding Decibel Therapeutics to a well-diversified portfolio.
Decibel Therapeutics Valuation on December 1, 2024
It is possible to determine the worth of Decibel Therapeutics on a given historical date. On December 1, 2024 Decibel was worth 3.1 at the beginning of the trading date compared to the closed value of 3.08. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Decibel Therapeutics stock. Still, in general, we apply an absolute valuation method to find Decibel Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Decibel Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Decibel Therapeutics' related companies.
Open | High | Low | Close | Volume | |
12/03/2024 | 3.10 | 3.26 | 2.97 | 3.08 | 0.00 |
Backtest Decibel Therapeutics | | | Decibel Therapeutics History | | | Decibel Therapeutics Valuation |
Decibel Therapeutics Trading Date Momentum on December 1, 2024
Decibel Therapeutics Fundamentals Correlations and Trends
By evaluating Decibel Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Decibel Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Decibel financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Decibel Therapeutics Stock history
Decibel Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Decibel is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Decibel Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Decibel Therapeutics stock prices may prove useful in developing a viable investing in Decibel Therapeutics
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Decibel Therapeutics, Inc. was incorporated in 2013 and is headquartered in Boston, Massachusetts. Decibel Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 62 people.
Decibel Therapeutics Stock Technical Analysis
Decibel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Decibel Therapeutics Period Price Range
Low | December 3, 2024
| High |
0.00 | 0.00 |
Decibel Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Decibel Therapeutics December 3, 2024 Market Strength
Market strength indicators help investors to evaluate how Decibel Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Decibel Therapeutics shares will generate the highest return on investment. By undertsting and applying Decibel Therapeutics stock market strength indicators, traders can identify Decibel Therapeutics entry and exit signals to maximize returns
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Decibel Stock
If you are still planning to invest in Decibel Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Decibel Therapeutics' history and understand the potential risks before investing.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Global Correlations Find global opportunities by holding instruments from different markets | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |